Targeted Inhibition of GATA-3 by Pyrrothiogatain: Implications for Adipocyte Biology and Inflammatory Response

Overview

Journal Cells

Publisher MDPI

Date 2025 Jan 24

PMID 39851528

Authors

Shamma Almuraikhy

Maha Alser

Khaled Naja

Aisha Al-Malki

Nayef A Mazloum

Mohamed A Elrayess

Affiliations

Soon will be listed here.

Abstract

GATA-3 is a master regulator of preadipocyte differentiation and function. Pharmacological or genetic targeting of GATA-3 will allow us to understand the function of GATA-3 in regulating metabolism, insulin signaling, and inflammation. Pyrrothiogatain, a novel small molecule inhibitor of GATA family proteins, has emerged as a promising tool for modulating GATA-3 activity. This study aims to investigate the specificity of Pyrrothiogatain in regulating GATA-3-mediated preadipocyte differentiation and adipokine secretion under normal and pathological conditions. Wild-type and GATA-3 knockout 3T3-L1 cells were treated with different concentrations of Pyrrothiogatain in the presence and absence of 4-hydroxy-2-nonenal (4HNE), an inducer of oxidative stress and impairment of adipogenesis. As expected, GATA-3 knockout cells exhibited enhanced adipogenic capacity, characterized by increased cell and lipid droplet sizes, and upregulated expression of key adipogenic markers including CEBPβ, PPARγ, and PGC-1α. Pyrrothiogatain treatment reduced cell proliferation in both wild-type and GATA-3 knockout 3T3-L1 cells, but did not alter their adipogenic capacity. Furthermore, Pyrrothiogatain lowered secreted IL-6 levels and attenuated 4-HNE-induced TNF-α elevation in wild-type, but not in GATA-3 knockout cells. Co-treatment of 4-HNE and Pyrrothiogatain led to increased cell size, suggesting complex interactions between oxidative stress and GATA protein inhibition. This effect was similar to GATA-3 knockout cells, indicating Pyrrothiogatain's potential to modulate cellular stress responses independently of GATA-3 inhibition. These results reveal that Pyrrothiogatain's effects on adipocyte biology extend beyond simple GATA-3 inhibition. While GATA-3 knockout primarily affects adipogenesis, Pyrrothiogatain modulates inflammatory responses and potentially cellular stress mechanisms without directly impacting adipocyte differentiation. This study provides new insights into the multifaceted actions of Pyrrothiogatain and highlights its potential as a therapeutic agent for lowering inflammation and oxidative-stress-related aspects of metabolic disorders, distinct from the direct modulation of adipogenesis.

References

Kim T, Jo S, Choi H, Park J, Kim M, Nojima H . Identification of Creb3l4 as an essential negative regulator of adipogenesis. Cell Death Dis. 2014; 5:e1527. PMC: 4260748. DOI: 10.1038/cddis.2014.490. View

Madani A, Majeed Y, Abdesselem H, Agha M, Vakayil M, Sukhun N . Signal Transducer and Activator of Transcription 3 (STAT3) Suppresses STAT1/Interferon Signaling Pathway and Inflammation in Senescent Preadipocytes. Antioxidants (Basel). 2021; 10(2). PMC: 7927067. DOI: 10.3390/antiox10020334. View

Tong Q, Tsai J, Hotamisligil G . GATA transcription factors and fat cell formation. Drug News Perspect. 2004; 16(9):585-8. DOI: 10.1358/dnp.2003.16.9.829340. View

Almuraikhy S, Kafienah W, Bashah M, Diboun I, Jaganjac M, Al-Khelaifi F . Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance. Diabetologia. 2016; 59(11):2406-2416. PMC: 5506102. DOI: 10.1007/s00125-016-4031-3. View

Al-Jaber H, Mohamed N, Govindharajan V, Taha S, John J, Halim S . In Vitro and In Vivo Validation of GATA-3 Suppression for Induction of Adipogenesis and Improving Insulin Sensitivity. Int J Mol Sci. 2022; 23(19). PMC: 9569927. DOI: 10.3390/ijms231911142. View

Yang H, Hu R, Sun H, Chen B, Li X, Chen J . 4-HNE induces proinflammatory cytokines of human retinal pigment epithelial cells by promoting extracellular efflux of HSP70. Exp Eye Res. 2019; 188:107792. DOI: 10.1016/j.exer.2019.107792. View

Moseti D, Regassa A, Kim W . Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules. Int J Mol Sci. 2016; 17(1). PMC: 4730365. DOI: 10.3390/ijms17010124. View

Ohta Y, Murakami T, Kawahara M, Haruta M, Takehara H, Tashiro H . Investigating the Influence of GABA Neurons on Dopamine Neurons in the Ventral Tegmental Area Using Optogenetic Techniques. Int J Mol Sci. 2022; 23(3). PMC: 8834722. DOI: 10.3390/ijms23031114. View

Elrayess M, Almuraikhy S, Kafienah W, Al-Menhali A, Al-Khelaifi F, Bashah M . 4-hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance. Free Radic Biol Med. 2017; 104:129-137. DOI: 10.1016/j.freeradbiomed.2017.01.015. View

Zhang X, Guo L, Huang X, Li Q, Chi M . 4-Hydroxynonenal Regulates TNF-α Gene Transcription Indirectly via ETS1 and microRNA-29b in Human Adipocytes Induced From Adipose Tissue-Derived Stromal Cells. Anat Rec (Hoboken). 2016; 299(8):1145-52. DOI: 10.1002/ar.23371. View

10.

Tong Q, Dalgin G, Xu H, Ting C, Leiden J, Hotamisligil G . Function of GATA transcription factors in preadipocyte-adipocyte transition. Science. 2000; 290(5489):134-8. DOI: 10.1126/science.290.5489.134. View

11.

Nomura S, Takahashi H, Suzuki J, Kuwahara M, Yamashita M, Sawasaki T . Pyrrothiogatain acts as an inhibitor of GATA family proteins and inhibits Th2 cell differentiation in vitro. Sci Rep. 2019; 9(1):17335. PMC: 6874683. DOI: 10.1038/s41598-019-53856-1. View

12.

Al-Mansoori L, Al-Jaber H, Madani A, Mazloum N, Agouni A, Ramanjaneya M . Suppression of GATA-3 increases adipogenesis, reduces inflammation and improves insulin sensitivity in 3T3L-1 preadipocytes. Cell Signal. 2020; 75:109735. DOI: 10.1016/j.cellsig.2020.109735. View

13.

Vakayil M, Madani A, Agha M, Majeed Y, Hayat S, Yonuskunju S . The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-β signaling. Sci Rep. 2024; 14(1):11886. PMC: 11126700. DOI: 10.1038/s41598-024-62508-y. View

14.

Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil G . Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol. 2005; 25(2):706-15. PMC: 543409. DOI: 10.1128/MCB.25.2.706-715.2005. View

15.

Shiroma Y, Takahashi R, Yamamoto Y, Tahara H . Targeting DNA binding proteins for cancer therapy. Cancer Sci. 2020; 111(4):1058-1064. PMC: 7156841. DOI: 10.1111/cas.14355. View

16.

Al-Jaber H, Al-Mansoori L, Elrayess M . GATA-3 as a Potential Therapeutic Target for Insulin Resistance and Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2020; 17(2):169-179. DOI: 10.2174/1573399816666200705210417. View

17.

Zarrouki B, Soares A, Guichardant M, Lagarde M, Geloen A . The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett. 2007; 581(13):2394-400. DOI: 10.1016/j.febslet.2007.04.048. View

18.

El-Arabey A, Abdalla M . GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance, and type 2 diabetes. Chem Biol Interact. 2022; 366:110141. DOI: 10.1016/j.cbi.2022.110141. View